Susquehanna International Group, LLP Intercept Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $2.5 Million - $4.68 Million	250,071 Added 215.68%	366,014 $6.79 Million
Q2 2023 Aug 11, 2023	SELL	$9.17 - $19.29 $961,492 - $2.02 Million	-104,852 Reduced 47.49%	115,943 $1.28 Million
Q1 2023 May 16, 2023	BUY	$12.53 - $21.71 $1.81 Million - $3.14 Million	144,797 Added 190.53%	220,795 $2.97 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $2.44 Million - $3.38 Million	-209,738 Reduced 73.4%	75,998 $940,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $3.35 Million - $5.4 Million	274,322 Added 2403.38%	285,736 $3.99 Million
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $658,841 - $1.15 Million	-58,668 Reduced 83.71%	11,414 $158,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $1.27 Million - $1.69 Million	-94,848 Reduced 57.51%	70,082 $1.14 Million
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $1.09 Million - $1.49 Million	-76,219 Reduced 31.61%	164,930 $2.69 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $1.26 Million - $1.99 Million	97,032 Added 67.33%	241,149 $3.58 Million
Q2 2021 Aug 11, 2021	BUY	$15.46 - $24.5 $519,564 - $823,371	33,607 Added 30.41%	144,117 $2.88 Million
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $1.36 Million - $2.65 Million	-70,289 Reduced 38.88%	110,510 $2.55 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $1.66 Million - $2.88 Million	67,853 Added 60.08%	180,799 $4.47 Million
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $650,223 - $888,920	-16,634 Reduced 12.84%	112,946 $4.68 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $2.9 Million - $5.71 Million	62,068 Added 91.94%	129,580 $6.21 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $111,833 - $274,506	-2,313 Reduced 3.31%	67,512 $4.25 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $3.88 Million - $8.4 Million	-67,664 Reduced 49.21%	69,825 $8.65 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $4.08 Million - $5.59 Million	-69,447 Reduced 33.56%	137,489 $9.12 Million
Q2 2019 Aug 16, 2019	BUY	$77.77 - $120.68 $1.3 Million - $2.01 Million	16,687 Added 8.77%	206,936 $16.5 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $12.6 Million - $19.5 Million	161,579 Added 563.58%	190,249 $15.1 Million
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $2.31 Million - $3.03 Million	-25,118 Reduced 46.7%	28,670 $3.21 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $2.37 Million - $3.49 Million	27,637 Added 105.68%	53,788 $5.42 Million
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $6.96 Million - $9.94 Million	-116,067 Reduced 81.61%	26,151 $2.2 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $3.84 Million - $4.9 Million	72,895 Added 105.15%	142,218 $8.75 Million
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $17.5 Million - $21.9 Million	-301,368 Reduced 81.3%	69,323 $4.05 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $21.1 Million - $44 Million	370,691	370,691 $21.5 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account